Recent Insider Activity: Stryker Corporation (SYK)

Stryker Corporation (NYSE:SYK) insider has recently participated in insider trading activity. Director, STRYKER RONDA E sold 6,000 shares for $ 575,423 via one transaction Feb 12. Following the transaction, the insider now owns 8,424,233 shares in total, priced at $820520294.2 as of Tuesday. Another notable insider trading was done by the same insider on Feb 11. STRYKER RONDA E sold 6,000 shares at an average price of $96.29 for a total of $577,737. Moreover, this insider carried out a sale of 6,000 shares at $98.37 each on Feb 10. The transaction amounted to $590,190. The insider also sold 6,000 shares for $581,405through one transaction Feb 09.

The stock has experienced a total of 67 insider trades in the past three months. These trades include 66 sell activities and 1 buy trades. Furthermore, over the past 12 months, the stock was traded 209 times by insiders. In 203 of these trades, the insider was a seller while an employee of the company was the buyer in just 6 instances.

On February 16, 2016, Stryker Corporation (SYK) announced a definitive agreement to acquire 100% of the stock of Physio-Control International, Inc. (“Physio-Control”) in an all cash transaction for $1.28 billion.  Physio-Control, which is a portfolio company of Bain Capital Private Equity, develops, manufactures and markets monitors/defibrillators, automated external defibrillators (AEDs) and CPR-assist devices along with data management and support services. The company was founded in 1955 and has a long history of innovation with products that target urgent patient care, specifically designed to improve survival rates and patient outcomes. The company`s portfolio is highly complementary to Stryker Medical`s EMS (Emergency Medical Services) offering and will drive a greater balance between capital and disposables. Physio-Control also brings an enhanced presence and infrastructure that will expand Stryker`s global footprint. Physio-Control sales for fiscal 2015 totaled $503 million, up 6% in constant currency over the prior year.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. The Orthopaedics segment offers implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices, as well as other medical devices for use in various medical specialties.